My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 352

    1.

    HIV-1 Vif, APOBEC, and intrinsic immunity.

    Goila-Gaur R, Strebel K.

    Retrovirology. 2008 Jun 24;5:51. Review.PMID: 18577210 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy.

    Izumi T, Shirakawa K, Takaori-Kondo A.

    Mini Rev Med Chem. 2008 Mar;8(3):231-8. Review.PMID: 18336343 [PubMed - indexed for MEDLINE]Related articles

    3.

    APOBEC proteins and intrinsic resistance to HIV-1 infection.

    Malim MH.

    Philos Trans R Soc Lond B Biol Sci. 2009 Mar 12;364(1517):675-87. Review.PMID: 19038776 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Antiviral roles of APOBEC proteins against HIV-1 and suppression by Vif.

    Romani B, Engelbrecht S, Glashoff RH.

    Arch Virol. 2009;154(10):1579-88. Epub 2009 Aug 12. Review.PMID: 19669862 [PubMed - indexed for MEDLINE]Related articles

    5.

    Natural resistance to HIV infection: The Vif-APOBEC interaction.

    Malim MH.

    C R Biol. 2006 Nov;329(11):871-5. Epub 2006 Aug 17.PMID: 17067930 [PubMed - indexed for MEDLINE]Related articles

    6.

    Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.

    He Z, Zhang W, Chen G, Xu R, Yu XF.

    J Mol Biol. 2008 Sep 12;381(4):1000-11. Epub 2008 Jun 28.PMID: 18619467 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Antiviral defense by APOBEC3 family proteins]

    Takaori A.

    Uirusu. 2005 Dec;55(2):267-72. Review. Japanese. PMID: 16557012 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Small-molecule inhibition of HIV-1 Vif.

    Nathans R, Cao H, Sharova N, Ali A, Sharkey M, Stranska R, Stevenson M, Rana TM.

    Nat Biotechnol. 2008 Oct;26(10):1187-92. Epub 2008 Sep 21.PMID: 18806783 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.

    Henriet S, Mercenne G, Bernacchi S, Paillart JC, Marquet R.

    Microbiol Mol Biol Rev. 2009 Jun;73(2):211-32. Review.PMID: 19487726 [PubMed - indexed for MEDLINE]Related articles

    10.

    APOBEC3 proteins and reverse transcription.

    Aguiar RS, Peterlin BM.

    Virus Res. 2008 Jun;134(1-2):74-85. Epub 2008 Feb 11. Review.PMID: 18262674 [PubMed - indexed for MEDLINE]Related articles

    11.

    Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.

    Zhang W, Chen G, Niewiadomska AM, Xu R, Yu XF.

    PLoS One. 2008;3(12):e3963. Epub 2008 Dec 17.PMID: 19088851 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Interaction between HIV-1 and APOBEC3 sub-family of proteins.

    Arriaga ME, Carr J, Li P, Wang B, Saksena NK.

    Curr HIV Res. 2006 Oct;4(4):401-9. Review.PMID: 17073615 [PubMed - indexed for MEDLINE]Related articles

    13.

    Turning up the volume on mutational pressure: is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3).

    Pillai SK, Wong JK, Barbour JD.

    Retrovirology. 2008 Mar 13;5:26.PMID: 18339206 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    APOBEC deaminases as cellular antiviral factors: a novel natural host defense mechanism.

    Franca R, Spadari S, Maga G.

    Med Sci Monit. 2006 May;12(5):RA92-8. Review.PMID: 16641889 [PubMed - indexed for MEDLINE]Related articles

    15.

    Identification of two distinct human immunodeficiency virus type 1 Vif determinants critical for interactions with human APOBEC3G and APOBEC3F.

    Russell RA, Pathak VK.

    J Virol. 2007 Aug;81(15):8201-10. Epub 2007 May 23.PMID: 17522216 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G.

    Holmes RK, Koning FA, Bishop KN, Malim MH.

    J Biol Chem. 2007 Jan 26;282(4):2587-95. Epub 2006 Nov 22.PMID: 17121840 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.

    Tian C, Yu X, Zhang W, Wang T, Xu R, Yu XF.

    J Virol. 2006 Mar;80(6):3112-5.PMID: 16501124 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    New insights into the role of Vif in HIV-1 replication.

    Schröfelbauer B, Yu Q, Landau NR.

    AIDS Rev. 2004 Jan-Mar;6(1):34-9. Review.PMID: 15168739 [PubMed - indexed for MEDLINE]Related articles

    19.

    Enhancing immunity to HIV through APOBEC.

    Harris RS.

    Nat Biotechnol. 2008 Oct;26(10):1089-90. No abstract available. PMID: 18846074 [PubMed - indexed for MEDLINE]Related articles

    20.

    Regulation of APOBEC3 proteins by a novel YXXL motif in human immunodeficiency virus type 1 Vif and simian immunodeficiency virus SIVagm Vif.

    Pery E, Rajendran KS, Brazier AJ, Gabuzda D.

    J Virol. 2009 Mar;83(5):2374-81. Epub 2008 Dec 24.PMID: 19109396 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk